about
IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease ActivityPostural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the "Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants": Case Report and Literature Review.A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.Sjögren's syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA).Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge.Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.Inflammatory myopathies and overlap syndromes: Update on histological and serological profile.Adult-onset Still disease: a rare disorder with a potentially fatal outcome.sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus.Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.Vitamins and systemic lupus erythematosus: to D or not to D.Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis.Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy.14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Sjögren's Syndrome.Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyTertiary Lymphoid Structures: Autoimmunity Goes LocalHistology of Sjögren’s SyndromeNew Biological Avenues for Sjögren’s SyndromeOutcome of Pregnancy in Italian Patients with Primary Sjögren SyndromeAuthors' reply: Human papillomavirus vaccine and primary ovarian failureCorrigendum to "Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects" [J. Autoimmun. 47C (2013) 1-16]Cryoglobulinemia in Sjögren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid TissuePhosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome
P50
Q21296720-03815873-6ABB-4DE6-926C-768F9BBBA49EQ33166316-5BEEA217-8230-4DFD-A8C2-C6FD677C86BBQ37361075-99DE5B09-F632-4798-BA98-F081C9FC171EQ38125512-98E17F90-B82A-4453-9587-54293F8B045CQ38163164-2D7571D8-E655-402E-AEDE-42429E16F30CQ38207763-CDEED9A0-BB46-4FC7-901B-6E6E15F8DD34Q38463009-47652E2C-1DA8-4D5C-8879-92D5F8C83242Q38544929-C9EE3547-28AF-4E9D-92B1-77B333DA95CFQ38703626-54015BD8-538C-41EF-83F5-6F2CB2D66151Q38815664-DD00A73C-8274-4D44-9F2C-502975A317D6Q39366004-E8BCDB8B-6831-4643-898D-7BA55F821ACFQ41666895-1C99CC99-67F3-44DD-AD55-CCA299210CCEQ41710244-AAF97262-89E6-4990-9186-40DB4C33FA7DQ42217081-AC3C5B73-E34F-4CAE-9AEF-2DA9B19B5BBDQ42255591-C232E2C7-CD1A-4564-BCFB-B365A25BC895Q43734009-646A86A2-BCF7-4ABB-B0C2-B752A20FA3D4Q43918394-D1151B4C-6F88-4696-8BCC-2B5281EBC42BQ45128834-44EF69FB-FE49-4189-BCFD-AD0F060B81CFQ48285249-509925D3-5A1C-4CAA-9C80-E9AD66779054Q51289629-7131B8FB-5533-4113-A673-F605ACACD157Q52671936-03EB82F1-A5ED-462C-81F8-299C364F4AA8Q58325876-5B4C72F6-6375-47AF-931E-07A782348435Q58746430-C3817BEA-DA04-4B87-A10E-6276D6FE11D8Q60810715-112553EB-27A8-47CA-B3F6-A1A742A0C601Q60810723-288E3CF0-1797-4787-AF73-7693CCB524BCQ61387495-F6EE2377-722B-41E8-A2B1-B7F5B32882C2Q87071367-34013443-4A88-46BC-A98B-B02F83E9DBDDQ87601697-2DC2271F-D040-4C7A-BB26-774E3EC091DAQ88069650-17CB68AA-A87F-43F4-AADD-00C3FA499048Q93347159-BB69A686-2AAB-4A1D-AD41-6DB48B3212F3
P50
description
researcher ORCID ID = 0000-0001-7802-1192
@en
wetenschapper
@nl
name
Serena Colafrancesco
@ast
Serena Colafrancesco
@en
Serena Colafrancesco
@es
Serena Colafrancesco
@nl
type
label
Serena Colafrancesco
@ast
Serena Colafrancesco
@en
Serena Colafrancesco
@es
Serena Colafrancesco
@nl
prefLabel
Serena Colafrancesco
@ast
Serena Colafrancesco
@en
Serena Colafrancesco
@es
Serena Colafrancesco
@nl
P1153
37077034100
P21
P31
P496
0000-0001-7802-1192